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Abstract
Background: We sought to estimate the numbers of patients affected and deaths avoided by
adopting the Leapfrog Group's recommended hospital procedure volume minimums for coronary
artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI). In addition to
hospital risk-adjusted mortality standards, the Leapfrog Group recommends annual hospital
procedure minimums of 450 for CABG and 400 for PCI to reduce procedure-associated mortality.
Methods: We conducted a retrospective analysis of a national hospital discharge database to
evaluate in-hospital mortality among patients who underwent PCI (n = 2,500,796) or CABG (n =
1,496,937) between 1998 and 2001. We calculated the number of patients treated at low volume
hospitals and simulated the number of deaths potentially averted by moving all patients to high
volume hospitals under best-case conditions (i.e., assuming the full volume-associated reduction in
mortality and the capacity to move all patients to high volume hospitals with no related harms).
Results: Multivariate adjusted odds of in-hospital mortality were higher for patients treated in low
volume hospitals compared with high volume hospitals for CABG (OR 1.16, 95% CI 1.10–1.24) and
PCI (OR 1.12, 95% CI 1.05–1.20). A policy of hospital volume minimums would have required
moving 143,687 patients for CABG and 87,661 patients for PCI from low volume to high volume
hospitals annually and prevented an estimated 619 CABG deaths and 109 PCI deaths. Thus,
preventing a single death would have required moving 232 CABG patients or 805 PCI patients from
low volume to high volume hospitals.
Conclusion: Recommended hospital CABG and PCI volume minimums would prevent 728 deaths
annually in the United States, fewer than previously estimated. It is unclear whether a policy
requiring the movement of large numbers of patients to avoid relatively few deaths is feasible or
effective.
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Background
Patients treated at hospitals with higher volumes of cardi-
ovascular procedures, including coronary artery bypass
graft (CABG) surgery and percutaneous coronary inter-
vention (PCI), are reported to have better outcomes than
patients treated at hospitals with lower volumes [1-3].
These data have led to a growing interest in using volume
to characterize hospital quality of care for cardiovascular
procedures by purchaser and consumer organizations
[4,5]. As part of its "Evidence-Based Hospital Referral"
guidelines, the Leapfrog Group, a coalition of large health
care purchasers that insure 34 million Americans, recom-
mended until 2003 that its members contract for selected
procedures, including CABG and PCI, only with hospitals
that met minimum volume thresholds [6]. Hospital risk-
adjusted mortality criteria were added to the Leapfrog
guidelines in 2003 [7].
Although proponents contend that implementing vol-
ume-based thresholds will reduce procedure-associated
mortality, there are limited data on the number of
patients affected by the adoption of volume minimums
and the magnitude of any potential benefits. One study of
patients hospitalized in California in 1997 suggested that
338 deaths might be prevented in that state each year by
adopting volume minimums for CABG and PCI [8], and
another study estimated that applying hospital volume
minimums for CABG and PCI nationwide would save
1,871 lives annually [9]. However, both studies relied on
estimates of hospital CABG [1] and PCI [3] volume-mor-
tality associations using New York state data from the late
1980s and early 1990s. Recent research by Birkmeyer and
Dimick [7] uses data from 2000 to estimate the volume-
mortality association and the national impact of the Leap-
frog volume standards, and finds that 148,508 CABG
cases would have to be moved to avert 594 deaths and
91,153 PCI cases would have to be moved to avert 547
deaths.
Because many purchasers have begun selective referral to
providers that meet these Leapfrog criteria, it is important
to understand the potential benefits and costs of the Leap-
frog quality improvement recommendations. To provide
an alternative, generalizable forecast of the potential con-
sequences of adopting a volume-based referral policy, we
conducted an evaluation of a hypothetical nationwide
implementation of the Leapfrog Group's volume-based
standards, the only criteria in effect until 2003, for CABG
and PCI using nationally representative data from 1998–
2001. We specifically sought to estimate the number of
patients at low volume hospitals who would need to be
moved to high volume hospitals and the number of




Our analysis was based on the Nationwide Inpatient Sam-
ple (NIS), a hospital discharge database from the Agency
for Healthcare Research and Quality's Health Care Utiliza-
tion Project [10]. As the largest publicly available all-payer
inpatient database in the United States, the NIS contains
administrative records for all hospitalizations in a ran-
domly selected national sample of non-governmental,
acute care hospitals. The 2001 NIS, the most recent ver-
sion of the NIS available at the time of our study, contains
information on more than 7.4 million discharges from
nearly 1,000 hospitals in 33 states, corresponding to
nearly 20% of all admissions to US non-federal hospitals
[11]. The NIS contains de-identified, hospitalization-level
data, including information on primary and secondary
diagnoses, demographic characteristics, procedure use,
length of stay, payer, total charges, and admission and dis-
charge status. Our study pooled data from the 1998, 1999,
2000, and 2001 NIS releases.
Study sample
We created separate, procedure-specific cohorts for hospi-
talizations in which a patient had any procedure code
indicating a CABG (International Classification of Dis-
eases, 9th Edition Clinical Modification [ICD-9-CM]
codes 36.10–36.2) or PCI (ICD-9-CM codes 36.00–36.06
and 36.09). Of the nearly 29 million records in the 1998,
1999, 2000, and 2001 NIS, we identified 306,942 hospi-
talizations with a CABG and 517,178 hospitalizations
with a PCI. We excluded patients under the age of 18 and
neonatal or obstetric admissions in order to restrict our
evaluation to a typical adult population. Hospitalizations
with missing data for sex, age, or mortality were also
excluded. To limit administrative data coding errors, we
excluded patients treated at hospitals with fewer than 10
CABGs in any year from the CABG cohort and patients
treated at hospitals with fewer than 5 PCIs in any year
from the PCI cohort. Finally, following the Leapfrog
Group's policy recommendation [12], we restricted our
analysis to admissions at hospitals located in US Census
Bureau-defined Metropolitan Statistical Areas, which are
clusters of counties comprising large population centers.
The two final unweighted procedure cohorts consisted of
296,135 hospitalizations for CABG drawn from 746 hos-
pital-years of data and 496,252 hospitalizations for PCI
drawn from 851 hospital-years of data. With the appropri-
ate NIS sampling weights, these data represented
1,496,937 hospitalizations for CABG from 3,365 hospi-
tal-years and 2,500,796 hospitalizations for PCI from
4,141 hospital-years.
Hospital volume groups
To assess the association of hospital CABG and PCI vol-
ume and patient mortality, hospitals were divided intoBMC Health Services Research 2005, 5:42 http://www.biomedcentral.com/1472-6963/5/42
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separate groups based on their annual volume. Hospitals
were categorized as low volume if their annual volume
was below the procedure-specific volume minimum rec-
ommended by the Leapfrog Group (450 cases for CABG,
400 cases for PCI) [7]. All other hospitals were considered
to be high volume.
Statistical analysis
Patient characteristics, including demographics, admis-
sion type, comorbidities, and payer, were compared
between patients treated in low volume hospitals and
high volume hospitals within each procedure cohort
using global chi-square analyses for categorical variables
and simple t-tests for continuous variables.
The principal study outcome was in-hospital mortality.
We compared crude rates of mortality between patients
treated in high volume hospitals and low volume hospi-
tals in each procedure cohort using global chi-square anal-
ysis. Unadjusted and multivariable logistic regressions
that accounted for the NIS survey design were conducted
within each procedure cohort to assess the association
between treatment at a low volume hospital and patient
mortality. Patient characteristics incorporated in the mul-
tivariable models, which were derived from previous
administrative data-based evaluations of CABG and PCI
and clinical judgment, included: sex, race (white, black,
other), age (<65 years, 65–74 years, ≥ 75 years), year,
admission source, urgency of admission (emergent,
urgent, elective, unknown/missing), coronary artery dis-
ease (principal diagnosis of MI [ICD-9-CM code 410], sec-
ondary diagnosis of MI, any non-MI coronary disease
diagnosis [ICD-9-CM codes 411–414], none), diabetes
(ICD-9-CM code 250), chronic obstructive pulmonary
disease (ICD-9-CM codes 490–496), hypertension (ICD-
9-CM codes 401–405), renal dysfunction (ICD-9-CM
codes 580–586), congestive heart failure (ICD-9-CM
codes 428, 402.01, 402.11, 402.91, 404.01, 404.11,
404.91), and peripheral vascular disease (ICD-9-CM
codes 440, 443).
In addition to factors common to both procedure models,
we added selected covariates to specific procedure volume
analyses. The multivariable model for CABG mortality
accounted for concomitant valve repair and other open
heart surgery procedures (ICD-9-CM procedure code 35),
use of an internal mammary graft (ICD-9-CM procedure
codes 36.15, 36.16), and a same admission PCI (ICD-9-
CM procedure codes 36.00–36.06, 36.09). The analysis of
hospital PCI volume controlled for multiple vessel PCI
(ICD-9-CM procedure code 36.05).
Estimating the effect of establishing hospital volume 
minimums
To assess the impact of hospital volume minimum policy
for CABG and PCI, we calculated the average annual
number of patients treated at low volume hospitals in
each procedure cohort. Observations were weighted using
NIS sampling weights to obtain nationally generalizable
estimates.
We then estimated the number of deaths that could be
prevented by the universal adoption of hospital volume
minimums using mortality estimates obtained from the
procedure-specific multivariable logistic regression mod-
els. Volume at low volume hospitals was modeled using a
logarithmic transformation based on previous studies
suggesting hospital volume-mortality associations exhibit
a log-linear relationship [13-15]. Volume at high volume
hospitals was modeled with a single dummy variable to
reflect the average volume-associated mortality effect in
high volume hospitals. An initial risk-adjusted probability
of mortality was calculated for each hospitalization using
the current distribution of patients across hospital volume
groups. To derive a "best case" estimate of the impact of a
hospital volume minimum policy, we assumed that all
patients at low volume hospitals could be transported to
high volume hospitals. A second risk-adjusted probability
of mortality was then calculated for hospitalizations
treated in low volume hospitals assuming that they had
been treated in a typical high volume hospital by setting
the hospital volume effect for low volume hospital
patients to the average hospital volume effect for patients
treated in high volume hospitals. This process removed
any measured volume-associated difference in mortality
between patients treated in low volume and high volume
hospitals. Differences in weighted risk-adjusted probabil-
ities between the two scenarios were summed across all
low volume hospital patients to determine the estimated
number of deaths averted by the adoption of hospital vol-
ume minimums for CABG and PCI.
Statistical analyses were conducted using SAS 8.2 (SAS
Institute, Cary, NC) and Stata 8.2 (Stata Corporation, Col-
lege Station, TX). Analysis of the NIS database was




The proportion of patients treated at low volume hospi-
tals was 14.0% for PCI and 38.4% for CABG. Mean
patient age was 64.2 for PCI and 66.0 for CABG, and was
generally comparable for patients treated in low volume
and high volume hospitals. A greater proportion of
patients treated at low volume CABG and PCI hospitals
were non-white, while a lower proportion representedBMC Health Services Research 2005, 5:42 http://www.biomedcentral.com/1472-6963/5/42
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Table 1: Patient characteristics across hospital volume groups
Characteristics Hospital CABG Volume Hospital PCI Volume
Overall Low (<450) High (≥ 450) P Overall Low (<400) High (≥ 400) P
% of patients (weighted) 100.0 38.4 61.6 - 100.0 14.0 86.0 -
% of hospital year groups* 100.0 69.8 30.2 - 100.0 45.1 54.9 -
Mean age, (SD) years 66.0 (0.07) 65.9 (0.08) 66.1 (0.11) 0.12 64.2 (0.08) 63.7 (0.12) 64.2 (0.09) <0.001
Age 0.11 <0.001
Less than 65 41.1 41.7 40.7 48.7 50.7 48.3
65–74 years 34.5 34.2 34.7 28.8 27.6 29.0
75 years of age and older 24.4 24.1 24.6 22.5 21.7 22.6
Male 69.5 69.4 69.5 0.90 65.5 64.4 65.7 <0.001
Race 0.014 0.016
White 64.2 59.2 67.3 63.3 56.7 64.4
Black 3.8 3.8 3.9 4.5 5.1 4.4
Other 7.5 9.5 6.2 7.3 10.1 6.9
Race not reported/missing 24.5 27.6 22.6 24.9 28.1 24.4
Primary payer <0.001 <0.001
Medicare 53.8 51.9 55.0 49.0 45.7 49.5
Medicaid 4.0 4.7 3.5 4.0 5.3 3.8
Private 37.3 37.4 37.3 41.2 40.6 41.4
Other/missing 4.9 6.0 4.2 5.8 8.4 5.4
Diabetes 29.5 29.8 29.3 0.14 24.9 25.4 24.8 0.12
Hypertension 58.6 58.0 58.9 0.098 54.1 53.0 54.3 0.022
COPD 17.3 17.5 17.2 0.37 11.2 11.9 11.0 0.002
Congestive heart failure 17.6 17.5 17.7 0.64 9.9 10.7 9.8 <0.001
Peripheral vascular disease 7.6 7.5 7.6 0.55 5.6 5.4 5.6 0.43
Renal disease 6.0 5.8 6.1 0.11 2.6 2.9 2.5 <0.001
Coronary disease <0.001 <0.001
MI as primary diagnosis 20.3 20.1 20.4 31.0 37.6 29.9
MI as secondary diagnosis 5.7 6.3 5.3 4.5 5.0 4.4
Other coronary artery disease 65.6 65.5 65.7 60.2 53.1 61.4
No coronary disease 8.4 8.1 8.6 4.3 4.3 4.3
Admission type <0.001 <0.001
Emergency 23.7 23.8 23.6 31.9 36.9 31.1
Urgent 25.2 22.1 27.1 26.1 23.6 26.5
Elective 41.5 38.6 43.4 32.3 21.5 34.1
Other/missing 9.6 15.6 5.9 9.6 18.1 8.2
Arrived by inter-hospital transfer <0.001 <0.001
Yes 18.0 11.5 22.0 18.2 9.0 19.7
No 78.8 85.4 74.7 78.4 88.4 76.8
Unknown 3.2 3.2 3.3 3.4 2.7 3.6
Year 0.59 0.17
1998 25.4 26.0 25.1 22.0 25.6 21.4
1999 23.7 21.5 25.1 22.2 24.2 21.9
2000 25.5 25.2 25.7 26.0 25.6 26.1
2001 25.3 27.4 24.0 29.8 24.6 30.6
Procedure-specific variables
Same admission PCI 2.8 3.3 2.4 <0.001 - - - -
Concomitant valve procedure 10.6 9.5 11.3 <0.001 - - - -
Internal mammary artery graft 16.8 13.4 18.8 <0.001 - - - -
Multivessel PCI - - - - 14.5 14.8 12.6 <0.001
Unless noted otherwise, findings are expressed as percentages
Percentages may not sum to 100 due to rounding
* Hospital year groups refer to the number of hospitals that contributed data in each year of the NIS. A hospital participating in the NIS over the 3 
year period would be considered to have contributed 3 hospital year groups to the analysis.BMC Health Services Research 2005, 5:42 http://www.biomedcentral.com/1472-6963/5/42
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elective admissions or patients received in transfer as com-
pared with patients treated at high volume hospitals for
both procedures. The proportion of CABG patients receiv-
ing internal mammary artery grafts was slightly greater in
high volume hospitals while the proportion of PCI
patients with a myocardial infarction was slightly higher
in low volume hospitals. Other patient characteristics,
including sex distribution and prevalence of comorbid
conditions, were generally comparable between patients
at low volume and high volume hospitals (Table 1).
Hospital procedure volume and mortality
Crude in-hospital mortality was 3.64% for patients under-
going CABG and 1.50% for patients undergoing PCI. In-
hospital mortality rates were higher for patients treated in
low volume hospitals compared with high volume hospi-
tals for CABG (3.85% vs. 3.51%, P = 0.002) and PCI
(1.96% vs. 1.43%, P < 0.001). Patients at low volume hos-
pitals remained at increased risk of in-hospital mortality
after multivariable adjustment for CABG (odds ratio [OR]
1.16, 95% confidence interval [CI] 1.10–1.24) and PCI
(OR 1.12, 95% CI 1.05–1.20) compared with patients at
high volume hospitals (Table 2).
Impact of hospital procedure volume minimums
Implementation of a hospital procedure volume mini-
mum policy for cardiovascular procedures would require
the transfer of an estimated 231,348 total patients each
year, 143,687 patients for CABG, and 87,661 for PCI. A
best-case estimate suggests the transfer of patients from
low volume to high volume hospitals annually could have
prevented 728 in-hospital deaths. The majority of annual
deaths prevented by the transfer of patients to high vol-
ume hospitals were for patients undergoing CABG (619
deaths, 4.5% of all CABG deaths), with 109 deaths (1.2%
of all PCI deaths) avoided among patients undergoing
PCI. Adoption of a hospital volume minimum policy
would thus require the transfer of 232 patients from low
volume to high volume CABG hospitals to avert a single
death, and 805 patients from low volume to high volume
PCI hospitals to avert a single death (Table 3).
Discussion
The nationwide implementation of a hospital volume
minimum policy for cardiovascular procedures based on
volume thresholds promoted by the Leapfrog Group [7]
would have required the annual redistribution of more
than 231,000 patients who underwent CABG or PCI at
low volume hospitals between 1998 and 2001. At best,
this redistribution would have resulted in approximately
728 fewer deaths annually, concentrated primarily among
patients who underwent CABG (619 deaths). This sug-
gests that previously reported mortality benefits associ-
ated with volume minimums for PCI may be overstated
(547 deaths averted vs. 109) [7]. Differences between our
estimates and previous ones are driven more by method-
ology than data. Whereas previous studies assumed that
all patients moved from low- to high-volume centers
would receive the same average mortality benefit, our
methodology calculated the expected benefit for each
patient at a low-volume center based on the volume of the
center and the patient's comorbidities.
The potential to avert up to 728 deaths each year through
the treatment of CABG and PCI patients at only high vol-
ume hospitals may be interpreted as sufficient evidence
for the adoption of a procedure volume minimum policy.
However, this benefit must also be considered in the con-
text of the required transfer of over 231,000 patients each
year from low volume to high volume hospitals. Because
the average absolute incremental increase in mortality
associated with treatment at a low volume hospital com-
Table 2: Patient mortality by hospital volume groups
Hospital CABG Volume
Overall Low (<450) High (≥ 450) P
Crude rates 3.6 3.9 3.5 0.002
Unadjusted odds ratio 
(95% CI)
- 1.10 (1.04–1.16) 1.00 [referent] 0.001
Adjusted odds ratio (95% 
CI)
- 1.16 (1.10–1.24) 1.00 [referent] <0.001
Hospital PCI Volume
Overall Low (<400) High (≥ 400) P
Crude rates 1.5 2.0 1.43 <0.001
Unadjusted odds ratio 
(95% CI)
- 1.37 (1.28–1.49) 1.00 [referent] <0.001
Adjusted odds ratio (95% 
CI)
- 1.12 (1.05–1.20) 1.00 [referent] 0.001BMC Health Services Research 2005, 5:42 http://www.biomedcentral.com/1472-6963/5/42
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pared with a high volume hospital is generally small
(<0.5%), particularly for patients undergoing PCI, a large
number of patients would need to be treated at high vol-
ume hospitals (805 for PCI) in order to avert a single
death. This number needed to treat is larger than that of
most current cardiovascular drugs and therapies, suggest-
ing only a modest benefit for any individual patient [16].
Moreover, the number of deaths attributable to treatment
at low versus high volume hospitals represents only a
small proportion of overall procedure mortality (4.5% of
CABG deaths, 1.2% of PCI deaths). Recent studies also
suggest substantial heterogeneity in CABG and PCI out-
comes among hospitals, including low volume hospitals
with better than predicted outcomes and high volume
hospitals with worse than predicted outcomes [17,18]. As
such, hospital volume may be both a modest and unreli-
able measure of any individual hospital's performance
[19].
Policies regulating hospital procedure volume minimums
may also have potential adverse consequences. Concen-
trating services among fewer providers may adversely
affect access to procedures in many areas of the country
[20]. Differences in patient characteristics between low
and high volume hospitals in our analysis suggest the sus-
pension of services at low volume hospitals may dispro-
portionately affect minorities and patients with Medicaid
insurance, groups with historically limited access to cardi-
ovascular care. A reduction in the number of CABG and
PCI providers may also result in higher prices for health
care purchasers as provider competition is reduced. Adop-
tion of volume thresholds may unwittingly motivate pro-
viders to treat patients with borderline indications in
order to meet volume minimums. Patients may not sup-
port regionalization of procedures associated with hospi-
tal volume minimums if they prefer receiving care at local,
low volume hospitals [21]. Each of these and other factors
requires consideration prior to adopting any hospital vol-
ume minimum policy.
Limitations
Although our analysis provides estimates of the mortality
reductions that may be achieved through hospital volume
minimums, we necessarily make several assumptions.
First, we assumed that high volume hospitals achieved
superior outcomes because of their higher volumes [22].
If high volume hospitals have better outcomes because of
patient selection or factors other than hospital volume
itself, the mortality benefit and number of lives saved
reported by transferring patients from low volume hospi-
Table 3: Volume and mortality estimates
CABG PCI
Current
Total procedures, n(%) 374,234 625,199
Performed at LVH, n(%) 143,687 87,661
Performed at HVH, n(%) 230,547 537,538
Total in-hospital deaths, n(%) 13,633 9,405
Performed at LVH, n(%) 5,535 1,719
Performed at HVH, n(%) 8,098 7,686
Adopting volume minimum policy
Total procedures, n(%) 374,234 625,199
Performed at LVH, n(%) 0 0
Performed at HVH, n(%) 374,234 625,199
Total in-hospital deaths, n(%) 13,014 9,296
Performed at LVH, n(%) 0 0
Performed at HVH, n(%) 13,014 9,296
Impact of adopting volume minimum policy
Procedures moved from LVH to HVH, n 143,687 87,661
Deaths averted, n 619 109
Number of procedures moved from LVH to HVH to avoid 1 death 232 805
Percent reduction in deaths 4.54% 1.16%BMC Health Services Research 2005, 5:42 http://www.biomedcentral.com/1472-6963/5/42
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tals may be overstated. Second, our analysis assumes that
all patients can be shifted from low volume hospitals to
high volume hospitals and accrue a hospital volume-asso-
ciated mortality benefit. No study to date has tested this
assertion, and its validity remains unknown [23]. Third,
because it is impossible to know the exact volume of the
high volume hospital to which a low volume hospital
patient would be transferred, we assumed that all low vol-
ume hospital patients would receive the average benefit of
being treated at a high volume hospital. Finally, our anal-
ysis assumes that redistributing patients across hospitals
has no adverse consequences.
Our study has a number of limitations. First, the NIS data-
base is based on administrative data, and may be suscep-
tible to hospital-based variations in coding practices.
Previous studies, however, have demonstrated that
administrative databases contain sufficient information
to evaluate hospital differences in procedure quality [24],
and the NIS is a comprehensive, nationally representative,
all-payer database that includes information on cardio-
vascular procedure use. Second, we evaluated in-hospital
mortality and were unable to assess other outcomes,
including procedural complications or post-discharge
events. However, the Leapfrog Group's volume recom-
mendations are predicated on a mortality reduction, not
improvement on other outcomes [6,7]. Third, the NIS
does not collect data concerning physician volume, and
thus we could not assess the effect of operator volume.
However, previous studies suggest hospital volume is
associated with outcomes even after accounting for oper-
ator volume [13,25,26]. Learning by doing and/or
(dis)economies of scale, which are not captured in this
analysis, may also influence estimates of the impact of a
hospital volume minimum policy. Finally, the NIS does
not contain unique patient identifiers, and the possible
inclusion of multiple patient admissions in our cohort
may violate statistical assumptions of independence.
Conclusion
Implementation of a hospital volume minimum policy
for CABG and PCI based on the Leapfrog Group's
Evidence Based Hospital Referral guidelines in effect until
2003 would have required the annual redistribution of
over 231,000 patients from low volume hospitals to high
volume hospitals between 1998 and 2001. This policy
would have resulted in, at best, an estimated 728 fewer
deaths annually, primarily among patients undergoing
CABG. These estimates rely on the unproven assumption
that simply directing all patients to high volume hospitals
would eliminate the full differential in mortality between
low and high volume hospitals. Further, given the uncer-
tain feasibility and potential adverse consequences,
requiring the movement of 232 patients for CABG or 805
patients for PCI between hospitals to avert a single death
may not be an effective policy. These issues deserve further
study before hospital procedure volume minimum poli-
cies for CABG and PCI are adopted more widely by
purchasers.
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